All Major Solid Tumors
Cancer Type
Tumor Tissue (FFPE)
Specimen Requirements
2-4 Working Days
Turnaround Time ¹
ACT Nonet™ is an RT-PCR customizable tissue panel. It covers 167 variants of 11 genes with U.S. FDA-approved targeted treatments. Including all NCCN guideline-recommended genes and high sensitivity (1~5% of DNA, 125 copies/reaction for RNA).
RT-PCR Customizable Tissue Panel
167
Variants
11
Specially Curated Genes
≥99.9%
Clinical sensitivity & specificity
Hallmarks of ACT Nonet™
Optimized
Save time, cost, and tissue slides
Novel
Include NCCN guideline recommended genes
Extensive
Genes with U.S. FDA-approved targeted treatments
Summary
•Thetest can detect the presence of 167 hotspot genetic alterations
•Limit of detection: 1-5% DNA mutation; 300 copies for RNA fusion
•Analytical sensitivity: >99.9%; Analytical specificity: >99.9%
Technical Specifications
RT-PCR
167 variants of 11 genes
Specimen Requirements2
Tumor tissue (FFPE)
Target Genes
ALK, ROS1, RET1, NTRK1/2/3, MET, EGFR, BRAF, KRAS, HER2
Documentation
Disclaimers / Footnotes
- Turnaround time starts from the date of receipt of approved samples at our CAP-accredited laboratory.
- Please refer to our specimen instructions.
